Background: Exercise is established as a treatment option in PAD, even though the molecular mechanisms are not yet fully understood. An animal model was developed to evaluate collateral growth through exercise. Methods: 12 weeks old healthy C57BL/6 mice were compared to 18 wk. old ApoE -/deficient mice, showing after 12 wk. of high caloric diet cardiovascular deficits. Ligation of the superficial femoral artery simulated acute limb occlusion. Both groups where exposed to freely accessible running wheels to evaluate training effects and in motion-restricting cages as control baseline. Hind limb perfusion was measured by LDPI pre-and postoperative at different points in time. At each of these points body weight was recorded as well as histological/morphometric Mm. adductores examinations were performed. Results: ApoE -/mice showed significant macroscopic arteriosclerotic changes and an increase in body weight compared to BL6, but no differences of distances were observed. LDPI on BL6 did not show differences between training and resting. There was a continuous improvement in reperfusion to d14 to stabilize at 70% of baseline. ApoE showed significant differences between training and control on d7 on which this reperfusion stabilized at 70% of baseline. It was shown that there is a difference (p<0,05) of perfusion between the animal strains immediately postoperative as well as on d3 and d7. There is no difference in size of collateral arteries between the groups. A significant increase of macrophages and a higher endothelial monocyte activity can be seen in the first week in ApoE mice with training. Conclusion: The running wheels were accepted by both groups. Due to pre-existing cardiovascular deficiencies ApoE -/mice were proven to be a suitable model to picture PAD. It was shown there is evidence that exercise significantly accelerates reperfusion through collateral growth, an increased endothelial proliferation activity and a higher accumulation of macrophages due to training.
Background: Venous grafts, used as conduits to bypass occluded arteries, have low patency levels due to extensive intimal hyperplasia (IH). This study aims to investigate the role of TLR3 and downstream Interferon Regulatory Factors (IRF) 3 and 7, regulators of type-I interferons (IFN) and pro-inflammatory cytokines in vein graft disease. Methods: Tlr3-/-, Irf3-/-, Irf7-/-and control mice (n¼7e9/ group) underwent vein graft surgery. At t28 immunohistochemical analysis and a RT2-profiler PCR array of TLRresponsive genes were performed. mRNA expression of TLR-responsive genes were measured in vein grafts and TLR3 ligand stimulated bone marrow-derived macrophages (BMM). Statistical analyses on parametric data were performed by using a 2-tailed Student's t-test to compare individual groups, Mann-Whitney test was used for nonparametric data. Results: PolyI:C stimulated BMM show increased expression of type-I IFN inducible genes Ifit and Mx1, indicating type-I IFN regulation downstream TLR3. Tlr3-/-vein grafts demonstrated 1.8-fold increased IH (p¼0.009) and increased macrophage influx (p¼0.002) compared to controls. Multiple type-I IFN inducible genes were down-regulated in Tlr3-/-vein grafts. PolyI:C stimulated BMM of Tlr3-/-mice showed reduced Ifit1 (75%, p¼0.003) and Mx1 (63%, p<0.0001) expression and increased Ccl2 (56%, p¼0.006) and Tnfa (51% p¼0.003) expression compared to controls. Irf3-/-and Irf7-/-vein grafts show increased IH (resp. 1.4-fold, p¼0.0003 and 1.7-fold, p¼0.04) including increased macrophage influx. Ifit1, Ifit3 and Isg15 were down-regulated in vein grafts of both strains. Irf3-/-and Irf7-/-BMM expressed significant lreduced IFNb whereas only Irf3-/-BMM showed reduced Ccl2 (93%, p¼0.007) and Tnfa (68%, p<0.0001) expression compared to control BMM. Conclusion: We here show that TLR3 is protective in vein grafts via downstream IRF3 and IRF7 dependent type-I IFN regulation and IRF3 dependent pro-inflammatory cytokine regulation.
Ischaemic Myotubes Stimulate Angiogenesis via Exosomes
Sarah Lewis, Julia König, Charlotte Lawson, Lucy Collinson, Janice Tsui University College London, UK Background: Skeletal myotube exosomes are important in the repair and regeneration of healthy muscle however, we have shown that myotubes in an ischaemic microenvironment will secrete exosomes that impair muscle differentiation, potentially contributing to muscle dysfunction in peripheral arterial disease (PAD). As PAD is a systemic vascular disease we now investigate the role of exosomes in the crosstalk between muscle and endothelial cells and the impact of ischaemic exosomes on angiogenesis. Eur J Vasc Endovasc Surg (2018) 56, e13ee20 Methods: Exosomes were isolated from C2C12 myoblasts (MB), myotubes (MT) and ischaemic myotubes (IMT) through ultracentrifugation. Presence of exosomes was confirmed using Nanosight, western blotting and electron microscopy (EM). PKH26 labelled exosomes were cocultured with human umbilical vein endothelial cells (HUVECS) for 12 and 24hrs. Exosome uptake was assessed by fluorescent microscopy and FACs. The functional effect of IMT-exosomes on HUVECs was assessed through angiogenesis assays. Results: Nanosight data confirmed exosome populations of similar size and frequency secreted by MTs and IMTs (MT-exosome peak 107nm, concentration 4.85e+008AE 2.74e+007particles/ml IMT-exosome peak 98nm, concentration 6.08e+008AE1.68e+007particles/ml). EM and western blotting showed that MT-and IMT-exosomes are similar in structure and positive for known exosomal markers CD81 and Alix. Co-culture of 25ul exosomes with HUVECs resulted in uptake of MB-MT-and IMT-exosomes over 24hrs. Angiogenesis assay demonstrated that IMT-exosomes stimulate tube formation in a concentration dependent manner. Conclusion: Our data demonstrates that muscle exosomes are readily taken up by HUVECs, suggesting a novel method of muscle-vasculature intercellular communication. An ischaemic microenvironment alters the exosomal message, which in turn stimulates angiogenesis. In ischaemia, clarifying the role of exosomes in angiogenesis may provide novel targets that can be manipulated for patient benefit.
Loss of Sphingosine-1-Phoshate Receptor 3 Expression is Associated with Atherosclerosis in Humans
Guenter Daum, Steffen Greulich, Chris Winter, Wolfgang Keil, Sabine Wipper University Heart Center, Hamburg, Germany Introduction and Objectives: A role for Sphingosine-1phosphate receptors (S1PR) in atherosclerosis has been suggested from animal experiments but no data from humans are available. This study was designed to measure the expression of S1PR in various human vascular beds and to analyze potential associations between receptor expression and plaque burden. Methods: Tissue samples from 6 arteries (coronary a., CO, carotid a., CA, ascending aorta , AS, descending aorta, DE, abdominal aorta, AB, and iliac a., IL) were collected from randomly selected people (N¼163) during autopsies. For each subject, a comprehensive plaque score (CPS) was generated based on plaque in the arteries harvested. Expression of S1PR1-3 was measured by qPCR and data were expressed as log2. Statistical analyses were performed by appropriate non-parametric tests. Results: Among the 6 arteries, expression of each of the three S1PR measured differs significantly. The highest expression of all S1PR was measured in CO and the lowest in AS and DE. In all 6 arteries, the highest positive correlation was found between S1PR1 and S1PR2 expression with Spearman coefficients (r) between 0.59 (P¼2xE-17) in IL and 0.74 (P¼1xE-29) in AS. When the expression of S1PR was compared between the different arteries, the most significant associations were always found for S1PR3. Most strikingly, subjects with increasing CPS show a considerable decrease in S1PR3 expression in all arteries, which is independent of age. Interestingly, S1PR3 expression also decreases with increasing CPS even in arteries that themselves were scored healthy. Conclusion: Loss of S1PR3 expression is associated with increasing plaque burden. This effect appears to be of systemic nature as also arteries are concerned that themselves are free of plaque. This finding underlines the systemic nature of atherosclerosis and identifies the S1P/S1PR3-axis as a potential target to slow progression of atherosclerosis in humans.
Nicotine Regulates Segmental Aortic Stiffening
Markus Wagenhäuser a,b , Isabel Schellinger a,b , Joshua Spin a,b , Hubert Schelzig a,b , Philip S. Tsao a,b a Heinrich-Heine-University Düsseldorf, Germany b Stanford University School of Medicine, USA Introduction: Vascular stiffness and aortic stiffness in particular contributes to the development of AAA. Differential segment-specific stiffness development, quantified via the "segmental aortic stiffness (SAS)"-gradient, in adjacent segments may be a major contributor. Nicotine is the major risk factor for AAA development. This study investigates how nicotine influences stiffness development in the abdominal (AS) and thoracic (TS) segment. Methods: Wildtype-mice (C57BL/6) were infused with nicotine for 40 days using osmotic mini pumps (20mg/KG/ day). Segmental aortic stiffness was analyzed using M-mode and pulse-wave velocity (PWV) ultrasound measurements. Thereafter, explanted aortae were used for myograph measurements and stiffness-related gene expression (Matrix-Metalloproteinase (MMP)-2, MMP-9, Col1A1, Col3A1) was analyzed. Results: Aortic PWV increased with nicotine (p<.05). In particular, stiffening for the AS occurred after 10 days (p<.05), while increase in aortic stiffness for the TS was only found after 40 days (p<.05). SAS was enhanced with nicotine vs. PBS for both time points. Stiffness-related genes were up-regulated after 40 days in both segments (p<.05). Discussion: Aortic stiffening is different for the TS and AS over a 40-day time course. SAS is enhanced with nicotine infusion based on stiffness-related gene expression. The TS has a higher capacity to withstand aortic stiffening, although the reason remains uncertain. Differences in stiffness development for the TS and AS may in part explain nicotine's role in promoting AAA. 
